Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A model for thrombin protection against endotoxin.

F B Taylor, A Chang, L B Hinshaw

    Thrombosis Research
    |October 15, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Visual environment shapes the social dynamics of coloration and competition in an African Cichlid Fish.

    The Journal of experimental biology·2026
    Same author

    Framework for AI integration into the undergraduate medical curricula: a scoping review.

    BMC medical education·2026
    Same author

    Application of machine learning algorithms to predict osteoporosis in postmenopausal women with type 2 diabetes mellitus.

    Journal of endocrinological investigation·2023
    Same author

    Novel role of estrogen receptor-α on regulating chondrocyte phenotype and response to mechanical loading.

    Osteoarthritis and cartilage·2021
    Same author

    Discontinuation Patterns and Cost Avoidance of a Pharmacist-Driven Methicillin-Resistant <i>Staphylococcus aureus</i> Nasal Polymerase Chain Reaction Testing Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia.

    Open forum infectious diseases·2021
    Same author

    Current assessment of parental and health professional perception of the colour of neonatal vomiting: Results of a scoping survey.

    Pediatric surgery international·2021

    This study examines how controlled doses of the blood-clotting protein thrombin can help animals survive lethal doses of bacterial endotoxin. By administering thrombin before endotoxin exposure, researchers observed improved survival rates and faster activation of the body's natural blood-thinning and clot-dissolving systems.

    Area of Science:

    • Thrombin protection research within hematology
    • Endotoxin pathophysiology studies in veterinary medicine

    Background:

    Bacterial endotoxin exposure often leads to fatal systemic inflammatory responses in mammalian models. Prior research has shown that severe coagulation disturbances frequently accompany this pathological state. No prior work had resolved whether controlled activation of the clotting cascade could mitigate these lethal effects. That uncertainty drove the investigation into specific enzymatic interventions. It was already known that endotoxin triggers widespread intravascular coagulation. This gap motivated the exploration of thrombin as a potential therapeutic agent. Previous studies focused primarily on the detrimental consequences of uncontrolled clotting. This analysis shifts the perspective toward protective mechanisms.

    Purpose Of The Study:

    The aim of this study is to determine if controlled thrombin administration protects against lethal endotoxin exposure. Researchers sought to resolve whether priming the coagulation system could alter the host response to systemic toxicity. This investigation addresses the hypothesis that early activation of anticoagulant pathways improves survival outcomes. The team examined the temporal dynamics of blood-thinning and clot-dissolving processes in a canine model. By comparing treated subjects to saline controls, the authors intended to isolate the protective effects of the enzyme. The motivation stems from the high mortality rates associated with endotoxin-induced coagulation failure. This work provides a framework for understanding how enzymatic modulation influences systemic resilience. The study seeks to clarify the relationship between specific dosing protocols and the subsequent physiological defense mechanisms.

    Keywords:
    coagulation cascadefibrinolytic activitysystemic inflammatory responsecanine model

    Frequently Asked Questions

    The researchers propose that thrombin triggers an immediate increase in anticoagulant and fibrinolytic activity. This rapid physiological shift allows treated subjects to counteract the harmful effects of endotoxin, whereas saline-treated subjects exhibit a delayed response that fails to prevent mortality.

    The study utilized Xa one-stage assays to measure anticoagulant capacity and fibrin degradation product assays to quantify fibrinolytic activity. These diagnostic tools were necessary to track the specific biochemical changes occurring in the blood following the administration of the toxin.

    The researchers state that the specific dosage of 0.5 U/kg/min for 90 minutes is necessary to achieve the observed protective effect. This controlled infusion rate ensures that the enzymatic activity is sufficient to prime the body without causing excessive, harmful clotting.

    Related Experiment Videos

    Main Methods:

    Review Approach involved evaluating the impact of controlled enzymatic infusions on canine survival rates. Investigators administered 0.5 U/kg/min of the clotting agent over a 90-minute period. Subjects then received a 30-minute infusion of the toxic challenge. Researchers compared these outcomes against a control group receiving only saline. The team monitored survival over a seven-day duration to determine long-term efficacy. Laboratory technicians performed serial blood tests to track coagulation and fibrinolysis markers. This systematic comparison allowed for the identification of distinct physiological patterns between the two cohorts. The experimental design focused on quantifying the temporal relationship between enzymatic priming and toxic exposure.

    Main Results:

    Key Findings From the Literature indicate that 9 out of 14 thrombin-treated subjects survived for seven days. Conversely, 13 out of 14 saline-treated subjects perished within 36 hours of the challenge. The survivors demonstrated an immediate increase in anticoagulant activity as measured by the Xa one-stage assay. These same subjects also exhibited enhanced fibrinolytic activity via fibrin degradation product assays. Subjects receiving saline failed to show these protective responses until the study concluded. The data show a significant survival benefit for those receiving the enzymatic pretreatment. These results establish a clear link between early biochemical responses and improved clinical outcomes. The findings highlight the importance of rapid physiological adaptation in the face of lethal endotoxin exposure.

    Conclusions:

    Synthesis and Implications suggest that thrombin administration confers a survival advantage against endotoxin challenges. The authors propose that this protective effect relies on the rapid initiation of anticoagulant pathways. Evidence indicates that successful outcomes correlate with early fibrinolytic activity following toxic exposure. These findings imply that timing of the enzymatic response dictates the clinical trajectory. The researchers note that saline-treated subjects failed to mount these defensive responses promptly. This review highlights the importance of immediate physiological adaptation to mitigate systemic toxicity. The data support the hypothesis that specific dosing regimens modulate host resilience. Future clinical applications may depend on optimizing these early biochemical shifts.

    The Xa one-stage assay serves as a quantitative measurement of the anticoagulant response. This data type allows investigators to differentiate between the rapid protective reaction seen in thrombin-treated dogs and the sluggish, ineffective response observed in the saline-treated control group.

    The researchers measured the phenomenon of fibrinolysis through fibrin degradation product assays. This measurement reveals that survivors exhibit enhanced clot-dissolving activity immediately after endotoxin infusion, a critical difference compared to the non-surviving subjects who show no such activity until the study concludes.

    The authors conclude that thrombin provides protection when administered in correct amounts. They suggest that this therapeutic benefit is intrinsically linked to the early activation of the body's natural blood-thinning and clot-dissolving systems during the initial stages of endotoxin exposure.